Last 12 months
Inside the activity.
0 purchase rows · 75 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 11 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 6 |
| Feb 2026 | 0 | 8 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 7 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 7 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2020 Filed Feb 12, 2020 00:02 UTC |
WILSON GAYLE EDirector
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 21,720 | $0.00 Strike: $19.63 | $0.00 |
DisclosureSEC source: 0001127602-20-004969 · form4.xml · derivative · entry 3 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,720 shares Expires 2020-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vesed quarterly over the first year of service and were fully vested on May 11, 2011. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 00:02 UTC |
WILSON GAYLE EDirector
|
SaleCommon Stock | 21,720 | $67.72 | $1,470,878.40 |
DisclosureSEC source: 0001127602-20-004969 · form4.xml · nonDerivative · entry 2 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,782 F1 · price: Sale prices reported for the transactions reported here range from $67.71 to $67.76. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 00:02 UTC |
WILSON GAYLE EDirector
|
Exercise / conversionCommon Stock | 21,720 | $19.63 | $426,363.60 |
DisclosureSEC source: 0001127602-20-004969 · form4.xml · nonDerivative · entry 1 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 19:51 UTC |
Wilfong Diane E.SVP, Controller & CAO
|
Exercise / conversionRestricted Stock Unit · Derivative | 779 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-005053 · form4.xml · derivative · entry 3 Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,431 Underlying: Common Stock · 779 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. F2 · derivative.expiration_date: The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 19:51 UTC |
Wilfong Diane E.SVP, Controller & CAO
|
Tax withholdingCommon Stock | 219 | $68.99 | $15,108.81 |
DisclosureSEC source: 0001127602-20-005053 · form4.xml · nonDerivative · entry 2 Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,594 Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 19:51 UTC |
Wilfong Diane E.SVP, Controller & CAO
|
Exercise / conversionCommon Stock | 779 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-005053 · form4.xml · nonDerivative · entry 1 Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,813 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 23:25 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 2,950 | $0.00 Strike: $24.30 | $0.00 |
DisclosureSEC source: 0001127602-20-005129 · form4.xml · derivative · entry 3 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,600 Underlying: Common Stock · 2,950 shares Expires 2022-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. F2 · derivative.exercise_date: The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 23:25 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
SaleCommon Stock | 2,950 | $69.32 | $204,494.00 |
DisclosureSEC source: 0001127602-20-005129 · form4.xml · nonDerivative · entry 2 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,690 Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 23:25 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
Exercise / conversionCommon Stock | 2,950 | $24.30 | $71,670.25 |
DisclosureSEC source: 0001127602-20-005129 · form4.xml · nonDerivative · entry 1 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,640 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 07, 2020 Filed Feb 10, 2020 23:25 UTC |
WOLD OLSEN PERDirector
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 20,282 | $0.00 Strike: $20.65 | $0.00 |
DisclosureSEC source: 0001127602-20-004703 · form4.xml · derivative · entry 6 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,282 shares Expires 2021-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested quarterly over the first year of service and were fully vested on May 12, 2012. Read SEC document |
| February 07, 2020 Filed Feb 10, 2020 23:25 UTC |
WOLD OLSEN PERDirector
|
SaleCommon Stock | 20,282 | $69.00 | $1,399,458.00 |
DisclosureSEC source: 0001127602-20-004703 · form4.xml · nonDerivative · entry 4 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,854 Read SEC document |
| February 07, 2020 Filed Feb 10, 2020 23:25 UTC |
WOLD OLSEN PERDirector
|
Exercise / conversionCommon Stock | 20,282 | $20.65 | $418,721.89 |
DisclosureSEC source: 0001127602-20-004703 · form4.xml · nonDerivative · entry 3 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 00:00 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
SaleCommon Stock | 1,426 | $70.00 | $99,820.00 |
DisclosureSEC source: 0001127602-20-004716 · form4.xml · nonDerivative · entry 5 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,690 Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 19:49 UTC |
Dickinson Andrew DEVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,818 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-004544 · form4.xml · derivative · entry 3 Dickinson Andrew D · CIK 0001310204 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,785 Underlying: Common Stock · 1,818 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. F2 · derivative.expiration_date: The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 19:49 UTC |
Dickinson Andrew DEVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 599 | $68.21 | $40,857.79 |
DisclosureSEC source: 0001127602-20-004544 · form4.xml · nonDerivative · entry 2 Dickinson Andrew D · CIK 0001310204 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,592 Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 19:49 UTC |
Dickinson Andrew DEVP, Chief Financial Officer
|
Exercise / conversionCommon Stock | 1,818 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-004544 · form4.xml · nonDerivative · entry 1 Dickinson Andrew D · CIK 0001310204 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,191 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 19:52 UTC |
Wilfong Diane E.SVP, Controller & CAO
|
Exercise / conversionRestricted Stock Unit · Derivative | 638 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-004546 · form4.xml · derivative · entry 5 Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,210 Underlying: Common Stock · 638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. F2 · derivative.expiration_date: The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 19:52 UTC |
Wilfong Diane E.SVP, Controller & CAO
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,228 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-004546 · form4.xml · derivative · entry 4 Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,848 Underlying: Common Stock · 1,228 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. F2 · derivative.expiration_date: The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 19:52 UTC |
Wilfong Diane E.SVP, Controller & CAO
|
Tax withholdingCommon Stock | 658 | $68.21 | $44,882.18 |
DisclosureSEC source: 0001127602-20-004546 · form4.xml · nonDerivative · entry 3 Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,034 Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 19:52 UTC |
Wilfong Diane E.SVP, Controller & CAO
|
Exercise / conversionCommon Stock | 638 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-004546 · form4.xml · nonDerivative · entry 2 Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 19:52 UTC |
Wilfong Diane E.SVP, Controller & CAO
|
Exercise / conversionCommon Stock | 1,228 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-004546 · form4.xml · nonDerivative · entry 1 Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 23:25 UTC |
WOLD OLSEN PERDirector
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 21,720 | $0.00 Strike: $19.63 | $0.00 |
DisclosureSEC source: 0001127602-20-004703 · form4.xml · derivative · entry 5 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,720 shares Expires 2020-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vested quarterly over the first year of service and were fully vested on May 11, 2011. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 23:25 UTC |
WOLD OLSEN PERDirector
|
SaleCommon Stock | 21,720 | $68.12 | $1,479,605.50 |
DisclosureSEC source: 0001127602-20-004703 · form4.xml · nonDerivative · entry 2 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,854 F1 · price: Sale prices reported for the transactions reported here range from $68.1000 to $68.1750. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 23:25 UTC |
WOLD OLSEN PERDirector
|
Exercise / conversionCommon Stock | 21,720 | $19.63 | $426,363.60 |
DisclosureSEC source: 0001127602-20-004703 · form4.xml · nonDerivative · entry 1 WOLD OLSEN PER · CIK 0001181185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,574 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2020 Filed Feb 11, 2020 00:00 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,728 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-004716 · form4.xml · derivative · entry 7 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,182 Underlying: Common Stock · 2,728 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F3 · derivative.exercise_date: The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. F3 · derivative.expiration_date: The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. Read SEC document |
| February 06, 2020 Filed Feb 11, 2020 00:00 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $40.56 | $0.00 |
DisclosureSEC source: 0001127602-20-004716 · form4.xml · derivative · entry 6 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,560 Underlying: Common Stock · 5,000 shares Expires 2023-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. Read SEC document |
| February 06, 2020 Filed Feb 11, 2020 00:00 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
Tax withholdingCommon Stock | 1,302 | $68.21 | $88,809.42 |
DisclosureSEC source: 0001127602-20-004716 · form4.xml · nonDerivative · entry 4 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,116 Read SEC document |
| February 06, 2020 Filed Feb 11, 2020 00:00 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
Exercise / conversionCommon Stock | 2,728 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-004716 · form4.xml · nonDerivative · entry 3 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,418 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| February 06, 2020 Filed Feb 11, 2020 00:00 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
SaleCommon Stock | 5,000 | $68.18 | $340,900.50 |
DisclosureSEC source: 0001127602-20-004716 · form4.xml · nonDerivative · entry 2 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,690 Read SEC document |
| February 06, 2020 Filed Feb 11, 2020 00:00 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
Exercise / conversionCommon Stock | 5,000 | $40.56 | $202,800.00 |
DisclosureSEC source: 0001127602-20-004716 · form4.xml · nonDerivative · entry 1 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,690 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:23 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
Tax withholdingCommon Stock | 4,587 | $64.30 | $294,944.10 |
DisclosureSEC source: 0001127602-20-002965 · form4.xml · nonDerivative · entry 3 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,690 Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:23 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
GrantCommon Stock | 4,126 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-002965 · form4.xml · nonDerivative · entry 2 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,277 F2 · shares: Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 2, 2017. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:23 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
GrantCommon Stock | 8,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-002965 · form4.xml · nonDerivative · entry 1 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,151 F1 · shares: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 1, 2018, and February 6, 2019. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:25 UTC |
Dickinson Andrew DEVP, Chief Financial Officer
|
GrantCommon Stock | 3,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-002968 · form4.xml · nonDerivative · entry 1 Dickinson Andrew D · CIK 0001310204 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,373 F1 · shares: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 1, 2018, and February 6, 2019. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:27 UTC |
O'Day Daniel PatrickDirector · Chairman & CEO
|
GrantCommon Stock | 19,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-002971 · form4.xml · nonDerivative · entry 1 O'Day Daniel Patrick · CIK 0001638643 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,204 F1 · shares: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 1, 2019. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met. Read SEC document |
| January 28, 2020 Filed Jan 30, 2020 21:29 UTC |
Horning SandraDirector
|
GrantRestricted Stock Unit · Derivative | 632 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-002759 · form4.xml · derivative · entry 2 Horning Sandra · CIK 0001638709 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 632 Underlying: Common Stock · 632 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences Inc.'s common stock. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences Inc.'s common stock. F3 · derivative.exercise_date: 100% of the restricted stock units will vest on January 28, 2021. F3 · derivative.expiration_date: 100% of the restricted stock units will vest on January 28, 2021. Read SEC document |
| January 28, 2020 Filed Jan 30, 2020 21:29 UTC |
Horning SandraDirector
|
GrantNon-qualified Stock Option (Right to Buy) · Derivative | 3,837 | $0.00 Strike: $64.36 | $0.00 |
DisclosureSEC source: 0001127602-20-002759 · form4.xml · derivative · entry 1 Horning Sandra · CIK 0001638709 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,837 Underlying: Common Stock · 3,837 shares Expires 2030-01-28 F1 · derivative.exercise_date: 25% of the shares subject to the option vest on each three-month anniversary measured from January 28, 2020 such that 100% of the shares subject to the option will be fully vested and exercisable on January 28, 2021. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 00:01 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 2,950 | $0.00 Strike: $24.30 | $0.00 |
DisclosureSEC source: 0001127602-20-001254 · form4.xml · derivative · entry 3 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,550 Underlying: Common Stock · 2,950 shares Expires 2022-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. F2 · derivative.exercise_date: The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 00:01 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
SaleCommon Stock | 2,950 | $64.63 | $190,658.50 |
DisclosureSEC source: 0001127602-20-001254 · form4.xml · nonDerivative · entry 2 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,064 Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 00:01 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
Exercise / conversionCommon Stock | 2,950 | $24.30 | $71,670.25 |
DisclosureSEC source: 0001127602-20-001254 · form4.xml · nonDerivative · entry 1 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,014 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 30, 2019 Filed Jan 2, 2020 21:19 UTC |
Lofton Kevin EDirector
|
GrantPhantom Stock · Derivative | 26.3107 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-000153 · form4.xml · derivative · entry 1 Lofton Kevin E · CIK 0001468818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,737.9795 Underlying: Common Stock · 26.3107 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| December 30, 2019 Filed Jan 2, 2020 21:30 UTC |
Whitley Richard JamesDirector
|
GrantPhantom Stock · Derivative | 66.9833 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-000167 · form4.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,970.5126 Underlying: Common Stock · 66.9833 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 00:11 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 5,900 | $0.00 Strike: $24.30 | $0.00 |
DisclosureSEC source: 0001127602-19-034297 · form4.xml · derivative · entry 3 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,500 Underlying: Common Stock · 5,900 shares Expires 2022-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. F2 · derivative.exercise_date: The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 00:11 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
SaleCommon Stock | 5,900 | $65.77 | $388,043.00 |
DisclosureSEC source: 0001127602-19-034297 · form4.xml · nonDerivative · entry 2 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,064 Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 00:11 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
Exercise / conversionCommon Stock | 5,900 | $24.30 | $143,340.50 |
DisclosureSEC source: 0001127602-19-034297 · form4.xml · nonDerivative · entry 1 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,964 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 27, 2019 Filed May 20, 2020 23:13 UTC |
Lofton Kevin EDirector
|
OtherCommon Stock | 13,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-017427 · form4.xml · nonDerivative · entry 1 Lofton Kevin E · CIK 0001468818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,641 F1 · shares: Gifted to a charitable trust. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 19:14 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $40.56 | $0.00 |
DisclosureSEC source: 0001127602-19-033740 · form4.xml · derivative · entry 3 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,560 Underlying: Common Stock · 15,000 shares Expires 2023-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 19:14 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
SaleCommon Stock | 15,000 | $66.85 | $1,002,808.50 |
DisclosureSEC source: 0001127602-19-033740 · form4.xml · nonDerivative · entry 2 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,064 F1 · price: Sale prices reported for the transactions reported here range from $66.85 to $66.88. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 19:14 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
Exercise / conversionCommon Stock | 15,000 | $40.56 | $608,400.00 |
DisclosureSEC source: 0001127602-19-033740 · form4.xml · nonDerivative · entry 1 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,064 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2019 Filed Nov 20, 2019 23:11 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $24.30 | $0.00 |
DisclosureSEC source: 0001127602-19-033438 · form4.xml · derivative · entry 7 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,400 Underlying: Common Stock · 10,000 shares Expires 2022-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.